Evidence map›Paper›PMID 27708927›Full record

ArticleEuropean journal of rheumatology2015

Sarcopenia in women with rheumatoid arthritis.

Sevil Ceyhan Doğan, Sami Hizmetli, Emrullah Hayta, Ece Kaptanoğlu, Taner Erselcan, Emel Güler

Abstract read
In one paragraph

Article in European journal of rheumatology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Sarcopenia in Rheumatoid arthritis. A narrative review.Journal of frailty, sarcopenia and falls · 2023
    Review
  13. Review
  14. Article
  15. Article
  16. Observational
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Sevil Ceyhan DoğanClinic of Physical Medicine and Rehabilitation, Cumhuriyet University Hospital, Sivas, Turkey.
Sami HizmetliClinic of Physical Medicine and Rehabilitation, Cumhuriyet University Hospital, Sivas, Turkey.
Emrullah HaytaClinic of Physical Medicine and Rehabilitation, Cumhuriyet University Hospital, Sivas, Turkey.
Ece KaptanoğluClinic of Physical Medicine and Rehabilitation, Cumhuriyet University Hospital, Sivas, Turkey.
Taner ErselcanDepartment of Nuclear Medicine, Cumhuriyet University Faculty of Medicine, Sivas, Turkey.
Emel GülerClinic of Physical Medicine and Rehabilitation, Kayseri Education and Research Hospital, Kayseri, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo assess sarcopenia status in women with rheumatoid arthritis (RA). MATERIAL AND

methodsThirty female patients with RA and 30 female controls without RA were enrolled in this study. Sarcopenia status in patients with RA was evaluated by assessing body composition using dual X-ray absorptiometry (DXA). C-reactive protein (CRP) levels and erythrocyte sedimentation rate (ESR) were measured, and body mass index (BMI) and Disease Activity Score (DAS28) were calculated. Because sarcopenia differs between men and women, the study groups comprised only females.

resultsIt was found that skeletal muscle index (SMI) was lower in patients with RA (5.83±0.807) than in controls (7.30±1.640). Sarcopenia (in females with an SMI of ≤5.75 kg/m

conclusionIt was found that SMI was decreased and sarcopenia risk was elevated in patients with RA and the risk was higher in non-obese patients.

Indexed as

DXARheumatoid arthritissarcopenia

Identifiers

PMID27708927
PMCPMC5047263

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.